Catalyst calendar
Data as of 2026-08-19 16:00 UTC · tracked universe polled every 15 minutes
Three kinds of date: a PDUFA date (the deadline the FDA sets itself to decide on a drug application), an AdCom (an FDA advisory-committee meeting that reviews it in public), and a readout window (when a trial's results are expected). Dates marked confirmed by the company come from an 8-K or press-release quote; our estimate is a rule-derived window off the trial's registered primary-completion date (see methodology) — never shown the same way. Today: 200 estimated readout windows and 0 disclosed PDUFA/AdCom dates.
Next 7 days
| Date | Ticker | Phase | Event |
|---|---|---|---|
| 2027-06-23 in 44w | $BPMC | Phase 2 | (PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A… NCT03731260 |
| 2027-06-25 in 44w | $APLS | Phase 2 | A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to… NCT07215390 |
| 2027-06-30 in 45w | $ALNY | Phase 2 | HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female… NCT07575308 |
| 2027-07-22 in 48w | $VRTX | Phase 2 | Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1… NCT07161037 |
| 2027-08-09 in 51w | $ALNY | Phase 2 | A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy NCT06393712 |
| 2027-10-14 in 60w | $ITCI | Phase 2 | Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety… NCT06701903 |
| 2027-12-28 in 71w | $ITCI | Phase 2 | A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of… NCT06651567 |
| 2028-01-26 in 75w | $REGN | Phase 2 | A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab… NCT05557591 |
| 2028-01-31 in 76w | $BIIB | Phase 2 | A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its… NCT07722546 |
| 2028-02-10 in 77w | $BIIB | Phase 2 | A Study to Learn About the Effects of Felzartamab Infusions in Adults With… NCT07219043 |
| 2028-02-16 in 78w | $MRTX | Phase 2 | A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated… NCT07415031 |
| 2028-03-07 in 81w | $ARGX | Phase 2 | ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy… NCT07284420 |
| 2028-04-01 in 84w | $ALNY | Phase 2 | A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate… NCT07553442 |
| 2028-06-02 in 93w | $VRTX | Phase 2 | Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With… NCT05312879 |
| 2028-06-30 in 97w | $BMRN | Phase 2 | A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0… NCT07126262 |
| 2028-07-28 in 101w | $ARGX | Phase 2 | A Study to Assess Efficacy and Safety of Efgartigimod in Adults With Sjogren's… NCT07760818 |
| 2028-09-30 in 110w | $ITCI | Phase 2 | A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of… NCT06540833 |